Use of Pfizer Drug in Children Is Backed
According to a recent story by the Associated Press, federal advisers recommended that Pfizer be allowed to market the painkiller Celebrex as a treatment for children with a severe form of arthritis, even though they were split on whether it was safe.
In a 15-1 vote, the advisers said that the benefits of the drug outweighed its risks for juvenile rheumatoid arthritis patients 2 years old and older. They also strongly recommended that its safety be monitored for years.
The Food and Drug Administration must now weigh the panel’s recommendation that it expand approval of Celebrex. The agency is not required to follow the advice of its expert panels, but it usually does. To find out more, please review the full article.
Post A Comment / Question